Legal Representation
Attorney
David L. May
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 8, 2014 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 8, 2014 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 7, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 5, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 5, 2014 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 5, 2014 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 6, 2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2013 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 11, 2013 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 30, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 22, 2013 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 8, 2013 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 30, 2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 29, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 29, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 29, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 26, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 26, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 26, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 18, 2013 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 28, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 25, 2013 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of eye conditions and diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005